Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0002036798-26-000002

Options or other derivatives

  • President and CEO acquired 890,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ALEXANDER MARGARET A. President and CEO 2026-01-04 Grant or award · Employee Stock Option (right to buy) +890,000 890,000 D
Loading xslF345X05/form4-01052026_050101.xml…